MedTrace Logo

Phenotypic Exploration of Autism Spectrum Disorders Retrospective and Prospective Data

NCT04923854 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2022-04-18

No results posted yet for this study

Summary

Autism Spectrum Disorders (ASD) are a heterogeneous group of severe developmental abnormalities of the nervous system characterized by deficits in social interaction and verbal and nonverbal communication affecting approximately 1% of the general population.

In 5-40% of cases, genetic factors are identified as the cause of these disorders.

Despite this unique definition and the advancement of techniques, ASD is still a clinically and genetically heterogeneous condition, as several hundred genes have been identified to date.

Primary Objective and Endpoint Primary Objective:

Exploration of phenotypic heterogeneity in patients with ASD.

Primary endpoint:

* Routine Care Clinical Investigation Criteria.
* Scores on assessment scales,

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Richard DELORME, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2026-07-01
Completion
2027-07-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04923854 on ClinicalTrials.gov